Psoriatic arthritis (PsA) costs continue to rise year after year,
Read morePsA Costs Continue to Rise; Drug Costs Drive Trend
Home »
To Improve PsA Outcomes, Address Common Comorbidities
Only about 30% or fewer of patients with psoriatic arthritis
Read moreBristol Myers Squibb Announces Deucravacitinib (BMS-986165) Demonstrated Superiority to Placebo and Otezla® (apremilast) in Pivotal Phase 3 Psoriasis Study
PRINCETON, N.J.–(BUSINESS WIRE) November 3, 2020 — Bristol Myers Squibb
Read moreNew ways of developing treatment of chronic inflammation
Researchers from Aarhus University Hospital and Aarhus University in Denmark
Read moreSkin in balance: Joint forces of polarity and cell mechanics
The cell polarity protein Par3 controls mechanic changes in the
Read morePain and gain: Skin nerves anticipate and fight infection
Pinch yourself. If you feel pain, it’s thanks to specialized
Read moreOctopus-inspired wearable sensor
Wearable electronics that adhere to skin are an emerging trend
Read moreNewly identified bacteria-killing protein needs vitamin A to work
People who have inadequate vitamin A in their diets are
Read moreSkin diseases are more common than we think
Skin diseases are ranked as the fourth most common cause
Read moreHidden genes may underlie autism severity, new study shows: Researchers link a complex unexamined gene family with autism severity
Scientists at the University of Colorado Anschutz Medical Campus have
Read more